vs
HomeTrust Bancshares, Inc.(HTB)与帕可Bio(PACB)财务数据对比。点击上方公司名可切换其他公司
HomeTrust Bancshares, Inc.的季度营收约是帕可Bio的1.2倍($53.6M vs $44.6M),帕可Bio同比增速更快(13.8% vs 3.7%),HomeTrust Bancshares, Inc.自由现金流更多($45.3M vs $-19.9M),过去两年帕可Bio的营收复合增速更高(7.3% vs 3.5%)
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司,总资产达43亿美元,在北卡、南卡、佐治亚和田纳西州共设有33家网点,旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
太平洋生物科学(加利福尼亚)公司是2004年成立的美国生物技术企业,专注于研发生产基因测序相关设备,还可实现新型实时生物观测。公司拥有两大核心测序平台:基于零模波导特性的单分子实时测序平台(SMRT),以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术(SBB)平台。
HTB vs PACB — 直观对比
营收规模更大
HTB
是对方的1.2倍
$44.6M
营收增速更快
PACB
高出10.2%
3.7%
自由现金流更多
HTB
多$65.3M
$-19.9M
两年增速更快
PACB
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $53.6M | $44.6M |
| 净利润 | — | $-40.4M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 37.0% | -92.3% |
| 净利率 | — | -90.4% |
| 营收同比 | 3.7% | 13.8% |
| 净利润同比 | — | -1802.7% |
| 每股收益(稀释后) | $0.93 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HTB
PACB
| Q4 25 | $53.6M | $44.6M | ||
| Q3 25 | $54.1M | $38.4M | ||
| Q2 25 | $54.4M | $39.8M | ||
| Q1 25 | $50.9M | $37.2M | ||
| Q4 24 | $51.7M | $39.2M | ||
| Q3 24 | $50.6M | $40.0M | ||
| Q2 24 | $50.6M | $36.0M | ||
| Q1 24 | $50.0M | $38.8M |
净利润
HTB
PACB
| Q4 25 | — | $-40.4M | ||
| Q3 25 | $16.5M | $-38.0M | ||
| Q2 25 | $17.2M | $-41.9M | ||
| Q1 25 | $14.5M | $-426.1M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | $13.1M | $-60.7M | ||
| Q2 24 | $12.4M | $-173.3M | ||
| Q1 24 | $15.1M | $-78.2M |
毛利率
HTB
PACB
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 41.4% | ||
| Q2 25 | — | 36.9% | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 25.0% | ||
| Q2 24 | — | 16.5% | ||
| Q1 24 | — | 29.1% |
营业利润率
HTB
PACB
| Q4 25 | 37.0% | -92.3% | ||
| Q3 25 | 38.5% | -101.1% | ||
| Q2 25 | 40.1% | -112.8% | ||
| Q1 25 | 36.2% | -1154.5% | ||
| Q4 24 | 35.4% | -390.1% | ||
| Q3 24 | 33.2% | -160.3% | ||
| Q2 24 | 31.3% | -488.3% | ||
| Q1 24 | 38.0% | -209.6% |
净利率
HTB
PACB
| Q4 25 | — | -90.4% | ||
| Q3 25 | 30.5% | -98.9% | ||
| Q2 25 | 31.6% | -105.4% | ||
| Q1 25 | 28.5% | -1146.8% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | 25.9% | -151.9% | ||
| Q2 24 | 24.6% | -481.3% | ||
| Q1 24 | 30.1% | -201.4% |
每股收益(稀释后)
HTB
PACB
| Q4 25 | $0.93 | $-0.11 | ||
| Q3 25 | $0.95 | $-0.13 | ||
| Q2 25 | $1.00 | $-0.14 | ||
| Q1 25 | $0.84 | $-1.44 | ||
| Q4 24 | $0.83 | $-0.44 | ||
| Q3 24 | $0.76 | $-0.22 | ||
| Q2 24 | $0.73 | $-0.64 | ||
| Q1 24 | $0.88 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $324.7M | $279.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $600.7M | $5.3M |
| 总资产 | $4.5B | $784.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
HTB
PACB
| Q4 25 | $324.7M | $279.5M | ||
| Q3 25 | $315.8M | $298.7M | ||
| Q2 25 | $297.2M | $314.7M | ||
| Q1 25 | $299.8M | $343.1M | ||
| Q4 24 | $279.2M | $389.9M | ||
| Q3 24 | $293.5M | $471.1M | ||
| Q2 24 | $294.2M | $509.8M | ||
| Q1 24 | $380.5M | $561.9M |
股东权益
HTB
PACB
| Q4 25 | $600.7M | $5.3M | ||
| Q3 25 | $595.8M | $36.1M | ||
| Q2 25 | $579.3M | $61.5M | ||
| Q1 25 | $565.4M | $91.6M | ||
| Q4 24 | $551.8M | $506.6M | ||
| Q3 24 | $540.0M | $453.1M | ||
| Q2 24 | $523.6M | $492.7M | ||
| Q1 24 | $513.2M | $649.0M |
总资产
HTB
PACB
| Q4 25 | $4.5B | $784.1M | ||
| Q3 25 | $4.6B | $803.2M | ||
| Q2 25 | $4.6B | $825.5M | ||
| Q1 25 | $4.6B | $860.8M | ||
| Q4 24 | $4.6B | $1.3B | ||
| Q3 24 | $4.6B | $1.5B | ||
| Q2 24 | $4.7B | $1.5B | ||
| Q1 24 | $4.7B | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $49.5M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | $45.3M | $-19.9M |
| 自由现金流率自由现金流/营收 | 84.5% | -44.6% |
| 资本支出强度资本支出/营收 | 7.8% | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $93.8M | $-114.1M |
8季度趋势,按日历期对齐
经营现金流
HTB
PACB
| Q4 25 | $49.5M | $-19.1M | ||
| Q3 25 | $-11.3M | $-18.7M | ||
| Q2 25 | $-8.8M | $-29.4M | ||
| Q1 25 | $71.7M | $-44.1M | ||
| Q4 24 | $45.4M | $-30.6M | ||
| Q3 24 | $43.8M | $-45.5M | ||
| Q2 24 | $5.9M | $-54.3M | ||
| Q1 24 | $-9.0M | $-75.7M |
自由现金流
HTB
PACB
| Q4 25 | $45.3M | $-19.9M | ||
| Q3 25 | $-12.0M | $-18.8M | ||
| Q2 25 | $-10.2M | $-29.9M | ||
| Q1 25 | $70.7M | $-45.4M | ||
| Q4 24 | $42.4M | $-32.3M | ||
| Q3 24 | $43.1M | $-46.3M | ||
| Q2 24 | $5.7M | $-55.7M | ||
| Q1 24 | $-9.6M | $-79.6M |
自由现金流率
HTB
PACB
| Q4 25 | 84.5% | -44.6% | ||
| Q3 25 | -22.2% | -48.9% | ||
| Q2 25 | -18.7% | -75.3% | ||
| Q1 25 | 138.7% | -122.3% | ||
| Q4 24 | 82.0% | -82.3% | ||
| Q3 24 | 85.1% | -115.7% | ||
| Q2 24 | 11.2% | -154.8% | ||
| Q1 24 | -19.2% | -205.0% |
资本支出强度
HTB
PACB
| Q4 25 | 7.8% | 1.9% | ||
| Q3 25 | 1.4% | 0.2% | ||
| Q2 25 | 2.5% | 1.4% | ||
| Q1 25 | 2.0% | 3.7% | ||
| Q4 24 | 5.9% | 4.1% | ||
| Q3 24 | 1.3% | 2.0% | ||
| Q2 24 | 0.5% | 4.1% | ||
| Q1 24 | 1.1% | 10.0% |
现金转化率
HTB
PACB
| Q4 25 | — | — | ||
| Q3 25 | -0.68× | — | ||
| Q2 25 | -0.51× | — | ||
| Q1 25 | 4.93× | — | ||
| Q4 24 | — | -12.93× | ||
| Q3 24 | 3.34× | — | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | -0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HTB
暂无分部数据
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |